GL1X · GenesisL1 explorer

Research workbench

Phosphodiesterase-9A in complex with inhibitor 4B

Analyse Phosphodiesterase-9A in complex with inhibitor 4B in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7F0I
Type
protein
Length
630 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Isoform PDE9A2 of high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9A
EC
3.1.4.35
Ligands
06A, ZN, MG
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIsoform PDE9A2 of high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)protein31672% helix, 0% strand—
BIsoform PDE9A2 of high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)protein31470% helix, 0% strand—

Ligands and binding sites

  • 06A · 1-cyclopentyl-6-[[(2R)-1-(6-fluoranyl-2-azaspiro[3.3]heptan-2-yl)-1-oxidanylidene-propan-2-yl]amino]-5H-pyrazolo[3,4-d]pyrimidin-4-one · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13570.720.8440MG, 06A
23100.700.8433MG, 06A
32170.530.7737empty
41310.460.7732empty

Interfaces

1 interface between chains.

  • A–B · 850 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 7F0I · phosphodiesterase-9A in complex with inhibitor 4b · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.